Phase II trials of 5-FU, doxorubicin, and cisplatin in advanced, measurable adenocarcinoma of the lung and stomach.
EL Cazap, FP Smith, RA Estevez, CA Alvarez… - Cancer treatment …, 1986 - europepmc.org
A combination of 5-FU (600 mg/m2 on Days 1 and 8), doxorubicin (40 mg/m2 on Day 1), and
cisplatin (75 mg/m2 on Day 1) has been used for treatment of 31 patients with advanced …
cisplatin (75 mg/m2 on Day 1) has been used for treatment of 31 patients with advanced …
[引用][C] Phase II trials of 5-FU, doxorubicin, and cisplatin in advanced, mesurable adenocarcinoma of the lung and stomach
EL CAZAP, C GISSELBRECHT… - Cancer treatment …, 1986 - pascal-francis.inist.fr
Phase II trials of 5-FU, doxorubicin, and cisplatin in advanced, mesurable adenocarcinoma
of the lung and stomach CNRS Inist Pascal-Francis CNRS Pascal and Francis Bibliographic …
of the lung and stomach CNRS Inist Pascal-Francis CNRS Pascal and Francis Bibliographic …
Phase II trials of 5-FU, doxorubicin, and cisplatin in advanced, measurable adenocarcinoma of the lung and stomach
EL Cazap, C Gisselbrecht, FP Smith… - Cancer treatment …, 1986 - pubmed.ncbi.nlm.nih.gov
A combination of 5-FU (600 mg/m2 on Days 1 and 8), doxorubicin (40 mg/m2 on Day 1), and
cisplatin (75 mg/m2 on Day 1) has been used for treatment of 31 patients with advanced …
cisplatin (75 mg/m2 on Day 1) has been used for treatment of 31 patients with advanced …